An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
2023
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
2023
Comparison between obese and non-obese nonalcoholic fatty liver disease
2023
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
2021
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
2021
The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry
2021
Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia.
2021
Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia.
